FDANonrulemakingFDA-2011-D-0082
Who commented on this docket
Draft Guidance for Industry on Clinical Pharmacogenomics: Premarketing Evaluation in Early Phase Clinical Studies; Availability
1 organizations filed 1 public comment on Draft Guidance for Industry on Clinical Pharmacogenomics: Premarketing Evaluation in Early Phase Clinical Studies; Availability, at the Food and Drug Administration. The comment window closed 5579d ago.
Organizations
1
Comments
1
RIN
—
Comment window
closed 5579d ago
Abstract
Status: OPEN
Commenters (1)
- American Medical Associationtrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.